文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

微针技术治疗痤疮瘢痕的安全性和有效性。

Safety and efficacy of microneedling technology in the treatment of acne scars.

机构信息

Ocean Clinic, Marbella, Spain.

Department of Hand, Plastic, and Aesthetic Surgery, Ludwig Maximilian University, Munich, Germany.

出版信息

J Cosmet Dermatol. 2021 Nov;20(11):3482-3491. doi: 10.1111/jocd.14502. Epub 2021 Oct 1.


DOI:10.1111/jocd.14502
PMID:34596936
Abstract

BACKGROUND: Current options for the reduction of acne scarring (eg, ablative laser resurfacing) are associated with considerable side effects and limitations in terms of patient population. Percutaneous collagen induction via microneedling poses an alternative treatment method due to its low rates of reported adverse events and side effects. OBJECTIVE: To assess the safety and effectiveness of microneedling treatments in reducing acne scars. METHODS: A total of 22 patients (18 females and 4 males) with a mean age of 38 ± 7.6 years were assessed regarding the appearance of facial acne scarring. Acne scars were assessed via the Acne Scar Assessment Scale (ASAS) and the Goodman and Baron acne scar grading scale before and after two/three treatments. Additionally, the post-interventional development of side reactions, adverse events, and patient-reported outcomes (eg, pain/discomfort, skin redness) was reported. RESULTS: Compared to baseline, the mean ASAS value was improved statistically significantly on average by 1.41 and 1.46 after the second treatment as assessed by the independent raters and the patients, respectively. In patients who received a total of three treatments, a statistically significant mean improvement in ASAS value of 1.35 and 1.66 compared to baseline was assessed by the independent raters and patients, respectively. No unexpected adverse events were reported. The severity and rate of side reactions decreased over the course of this study. CONCLUSION: Microneedling treatments can pose a safe and effective option in the reduction of acne scarring. In this study, microneedling helped achieving a significant reduction of acne scars while showing high patient safety.

摘要

背景:目前用于减少痤疮疤痕(例如,磨皮激光换肤)的方法存在相当大的副作用和患者人群方面的局限性。微针穿刺诱导的经皮胶原诱导因其不良反应和副作用发生率低,成为一种替代治疗方法。 目的:评估微针治疗减少痤疮疤痕的安全性和有效性。 方法:共评估了 22 名(18 名女性和 4 名男性)年龄平均为 38 ± 7.6 岁的患者面部痤疮疤痕的外观。痤疮疤痕采用痤疮疤痕评估量表(ASAS)和 Goodman 和 Baron 痤疮疤痕分级量表进行评估,在两次/三次治疗前后进行评估。此外,还报告了干预后不良反应、不良事件和患者报告的结果(例如,疼痛/不适、皮肤发红)的发展情况。 结果:与基线相比,独立评估者和患者分别评估的第二次治疗后平均 ASAS 值分别平均改善了 1.41 和 1.46。接受总共三次治疗的患者中,独立评估者和患者分别评估的 ASAS 值平均改善了 1.35 和 1.66,与基线相比有统计学显著差异。未报告意外不良事件。不良反应的严重程度和发生率在研究过程中降低。 结论:微针治疗可作为减少痤疮疤痕的安全有效选择。在这项研究中,微针治疗有助于显著减少痤疮疤痕,同时显示出较高的患者安全性。

相似文献

[1]
Safety and efficacy of microneedling technology in the treatment of acne scars.

J Cosmet Dermatol. 2021-11

[2]
Skin microneedling for acne scars associated with pigmentation in patients with dark skin.

J Cosmet Dermatol. 2018-6

[3]
Microneedling with topical vitamin C versus microneedling with topical insulin in the treatment of atrophic post-acne scars: A split-face study.

Dermatol Ther. 2022-5

[4]
Treatment of Acne Scars with Microneedling and Chemical Reconstruction of Scarred Skin Therapy (CROSS) Using Penol/Croton Oil Combination.

J Drugs Dermatol. 2024-6-1

[5]
Skin microneedling plus platelet-rich plasma versus skin microneedling alone in the treatment of atrophic post acne scars: a split face comparative study.

J Dermatolog Treat. 2018-5

[6]
Fractional Erbium-Doped Yttrium Aluminum Garnet Laser Versus Microneedling in Treatment of Atrophic Acne Scars: A Randomized Split-Face Clinical Study.

Dermatol Surg. 2017-1

[7]
Microbotox (Mesobotox) versus microneedling as a new therapeutic modality in the treatment of atrophic post-acne scars.

J Cosmet Dermatol. 2022-12

[8]
Microneedling for acne scars in Asian skin type: an effective low cost treatment modality.

J Cosmet Dermatol. 2014-9

[9]
A Split-Face Study to Evaluate Efficacy of Autologous Injectable Platelet-Rich Fibrin With Microneedling Against Microneedling With Normal Saline (Placebo Control) in Atrophic Acne Scars.

Dermatol Surg. 2023-10-1

[10]
Combined autologous platelet-rich plasma with microneedling versus microneedling with non-cross-linked hyaluronic acid in the treatment of atrophic acne scars: Split-face study.

Dermatol Ther. 2021-1

引用本文的文献

[1]
An Assessment of Current Clinician- and Patient-Reported Outcome Measures for Acne Scarring and Dyspigmentation: A Scoping Review.

J Invest Dermatol. 2025-2-27

[2]
Microneedling with Topical Insulin Versus Microneedling with Non-Cross-Linked Hyaluronic Acid for Atrophic Post-Acne Scars: A Split-Face Study.

Dermatol Pract Concept. 2024-7-1

[3]
Comparing the efficacy and safety of microneedling and its combination with other treatments in patients with acne scars: a network meta-analysis of randomized controlled trials.

Arch Dermatol Res. 2024-8-7

[4]
Acne treatment: research progress and new perspectives.

Front Med (Lausanne). 2024-7-10

[5]
Microneedling with a Novel, n-3-PUFA-Rich Formulation Accelerates Inflammation Resolution to Improve Skin Recovery Outcomes in Adults with Healthy Skin.

Dermatol Ther (Heidelb). 2023-12

[6]
A split-face, blind, randomized placebo-controlled clinical trial investigating the efficacy and safety of hyaluronic acid filler for the correction of atrophic facial scars.

J Cosmet Dermatol. 2022-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索